A joint Australian-Italian study has found traces of the anti-depressant fluoxetine in lakes and rivers, potentially affecting freshwater fish. The residue of pharmaceuticals like fluoxetine ends up in waterways due to human waste and improper disposal of medication. Even after being treated at waste treatment plants, pharmaceutical residues can still be absorbed by fish, impacting their health and fertility. The study found that male guppies exposed to fluoxetine had changes in their reproductive organs, affecting sperm mobility and fertility.
In addition to fluoxetine, a variety of other pharmaceuticals and contaminants are found in freshwater, including analgesics, antibiotics, and heavy metals. Scientists emphasize the need for modified water treatment processes to filter out pharmaceuticals, urging governments to take action. While more research is needed to understand the full impact of these contaminants on the environment, improving monitoring and compliance standards can help mitigate their effects in freshwater environments.
The study’s author, Giovanni Polverino, highlighted the importance of raising awareness about the impact of pharmaceutical pollution on aquatic ecosystems and engaging with policymakers to implement measures that can prevent these pollutants from entering the environment. Although wastewater treatment is effective at cleaning up water, it currently does not address the issue of pharmaceutical contamination. Experts recommend a proactive approach to address the problem and protect the health of aquatic life and humans.
Source
Photo credit www.aljazeera.com